Flu's Evolution Strategy Strikes Perfect Balance

June 10, 2010
Flu virus

(PhysOrg.com) -- Scientists have uncovered the flu's secret formula for effectively evolving within and between host species: balance. The key lies with the flu's unique replication process, which has evolved to produce enough mutations for the virus to spread and adapt to its host environment, but not so many that unwanted genomic mutations lead to the flu's demise (catastrophic mutagenesis). These findings overturn long-held assumptions about how the virus evolves.

Better understanding how the flu virus replicates and evolves to infect new hosts will help scientists find new ways to fight the flu. One option is the development of therapies that take advantage of the new findings by promoting mutagenesis - treatments designed to generate increased that will ultimately kill the virus.

"These new findings give us insights into how we may be able to control viral evolution," said Baek Kim, Ph.D., professor in the department of Microbiology and Immunology at the University of Rochester Medical Center and lead study author. "This research presents an attractive strategy for tackling the flu - making the kill itself by amplifying the number of mutations made beyond the desired level, which is lethal for the virus."

In the new study, published in the online journal , scientists disprove the widely accepted idea that the flu virus evolves so efficiently due to its error-prone replication process. The virus requires a high number of genomic mutations to jump from one species to another, such as from a pig to a human, and up until this point scientists believed the error-prone replication process facilitated the mutations needed for the flu to spread. In reality, its replication process is not prone to errors; rather, the virus goes through multiple rounds of RNA genome replication in each viral infection cycle, allowing it to produce more than enough genomic mutations necessary for viral evolution and host adaptation.

The flu's accurate replication process also keeps the virus in check. Given the flu's multiple rounds of RNA replication per infection, too many mutations would result if the process was highly prone to error, leading to catastrophic mutagenesis.

"The perception has always been that the flu virus mutates a lot, and in order to do that it has to have an enzyme that makes a lot of mistakes, but Kim's work shows that is not the case at all," said David Topham, Ph.D., associate professor of Microbiology and Immunology at Rochester and an expert on how the body fights the flu. "There is a selection pressure, perhaps related to the flu's multiple replication strategy, which helps certain mutations develop and avoid immunity so that the virus can spread."

Topham, Kim and John Treanor, M.D., chief of the Infectious Diseases Division of the Department of Medicine at Rochester, lead the New York Influenza Center of Excellence (NYICE), which funded the current research. NYICE is one of five centers nationwide designated by the National Institutes of Health to further our understanding of the flu virus through basic research and surveillance studies, and to facilitate the nation's preparations for a potential pandemic.

To pin down the mechanisms behind flu virus evolution, researchers conducted unique biochemical analyses comparing flu virus replication to HIV replication, which has been well characterized in past research. While both viruses require efficient mutation production to adapt and thrive in their host environments, they replicate their genetic information very differently. HIV has evolved so that the virus only has a few chances to replicate its genome per infection and generate sufficient mutations, while the flu virus has ample chances to make and accumulate genomic mutations in each viral infection cycle.

At the center of the new finding are the polymerases, or enzymes, responsible for viral replication. Because the AIDS virus only has a few opportunities to replicate its genome in each infection cycle, its polymerases are highly error prone in order to generate sufficient mutations within its limited replication window. In contrast, the polymerases are high-fidelity enzymes - they are accurate and not prone to error. Even without copious changes in genetic material, the flu's multiple replication strategy allows the virus to produce genomic mutations sufficient for viral evolution and host adaptation.

"Kim's team has developed some very important new methodology for studying the function of the flu polymerase that could easily result in the development of new antivirals or other methods to control influenza," said Treanor. "I think this research will stimulate a lot of additional research about the flu polymerase."

Explore further: Pandemic mutations in bird flu revealed

Related Stories

Pandemic mutations in bird flu revealed

July 9, 2008

Scientists have discovered how bird flu adapts in patients, offering a new way to monitor the disease and prevent a pandemic, according to research published in the August issue of the Journal of General Virology. Highly ...

The way to a virus' 'heart' is through its enzymes

July 9, 2008

The arrival of bluetongue virus (BTV) in the UK last year posed a major threat to the economy and the increasing temperatures of our changing climate mean it is here to stay. If we are to fight this disease, which has had ...

Bird flu leaves the nest -- adapting to a new host

August 26, 2009

Current research suggests that viral polymerase may provide a new therapeutic target for host-adapted avian influenza. The related report by Gabriel et al, "Spread of Infection and Lymphocyte Depletion in Mice Depends on ...

Recommended for you

Cow gene study shows why most clones fail

December 9, 2016

It has been 20 years since Dolly the sheep was successfully cloned in Scotland, but cloning mammals remains a challenge. A new study by researchers from the U.S. and France of gene expression in developing clones now shows ...

Blueprint for shape in ancient land plants

December 9, 2016

Scientists from the Universities of Bristol and Cambridge have unlocked the secrets of shape in the most ancient of land plants using time-lapse imaging, growth analysis and computer modelling.


Adjust slider to filter visible comments by rank

Display comments: newest first

5 / 5 (2) Jun 10, 2010
It always comes back to the Evolutionary Stable Strategy.
1.5 / 5 (2) Jun 10, 2010
Fantastic Article. Are you trying to say... that the flu can be killed with the flu? If so, this is not like a snake bight where you can milk the snake & make the cure... or can you? Whom...Please keep me updated on this subject. Thank you. Sincerely, Kristy S.
schweinfurt707@yahoo.com or kristylvsjets@gmail.com
1 more u can twitter me @kristylvsjets.com
not rated yet Jun 10, 2010
One option is the development of therapies that take advantage of the new findings by promoting mutagenesis - treatments designed to generate increased mutations that will ultimately kill the virus.

I wouldn't exactly recommend this method of combating the flu. It doesn't take much to go from minor sniffles to killer superflu when it comes to mutation. I'd rather we didn't push rapid mutation as a cure.
1 / 5 (2) Jun 10, 2010
I wouldn't exactly recommend this method of combating the flu.

Sounds more or less like making the ultimate doomsday weapon, rather than making a cure.

Articles like this shouldn't even be posted publicly. Genetic technology is as dangerous or more so than nuclear weapons, because the materials needed to monkey around with it are cheaper and less restricted.

All it takes is one Muslim "borrowing" from these people's research to end the modern world...
not rated yet Jun 10, 2010
I disagree QC. Biology is a powerful technology, however, when you can combat an item with itself it greatly blunts the effects.
not rated yet Jun 10, 2010
Yes really missunderstanding of the case, the more mutations wont help for shure.....the viruses use the sintetic aparat of the cell , they get their DNA or RNA which tells to the cell what protein to make , the copies of the DNA or RNA is made by the same enzime which the cell is using for its own replication. Maybe they should compare the DNA viruses vs RNA, the RNA is much more unstable and more mistaces accur, thats why this type of viruses are more hard to kill, HIV and flu are RNA viruses, but the fact that we have DNA and RNA viruses shows that the both strategies work.
not rated yet Jun 10, 2010
I cant see how they will increase the mutation of the viruses, without to increace the mutation of the ordinary cells(and this will increace cancer with shure), and if they do what will be the benefit....it is beneficial but for the virus
not rated yet Jun 10, 2010
My point is that to me, it seems like instead of one deadly flu virus, you'd end up with 50 of them, each different enough to require a different vaccine.
not rated yet Jun 10, 2010
My point is that to me, it seems like instead of one deadly flu virus, you'd end up with 50 of them, each different enough to require a different vaccine.

I agree, but, once we expand our knowledge of the biology toolkits we're experimenting with now, once we can obtain a sample of a virus it's a simple matter of time and effort to eradicate it entirely.

There was a very good TED talk about vaccination. I can't find the link for the life of me, but, one of the primary statements was on the shape of influenza genetics. All influenza proteins have a uniform characteristic, which assists them in penetrating cells. We've had some success finding "keys" that fix this biological "lock" and render the virus useless across multiple strains. Once we finalize an influenza "skeleton key" the virus will be all but a distant memory.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.